BlackRock’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-2,085
| Closed | -$23.3K | – | 5714 |
|
|
2022
Q4 | $23.3K | Sell |
2,085
-502,288
| -100% | -$5.61M | ﹤0.01% | 5278 |
|
|
2022
Q3 | $2.83M | Sell |
504,373
-28,911
| -5% | -$162K | ﹤0.01% | 3934 |
|
|
2022
Q2 | $2.31M | Sell |
533,284
-558,550
| -51% | -$2.42M | ﹤0.01% | 4112 |
|
|
2022
Q1 | $12.7M | Sell |
1,091,834
-33,680
| -3% | -$392K | ﹤0.01% | 3377 |
|
|
2021
Q4 | $20.6M | Buy |
1,125,514
+95,344
| +9% | +$1.74M | ﹤0.01% | 3200 |
|
|
2021
Q3 | $12.2M | Buy |
1,030,170
+51,502
| +5% | +$610K | ﹤0.01% | 3530 |
|
|
2021
Q2 | $16.8M | Buy |
978,668
+240,461
| +33% | +$4.13M | ﹤0.01% | 3346 |
|
|
2021
Q1 | $13.5M | Buy |
738,207
+233,797
| +46% | +$4.27M | ﹤0.01% | 3352 |
|
|
2020
Q4 | $9.49M | Buy |
504,410
+14,439
| +3% | +$272K | ﹤0.01% | 3322 |
|
|
2020
Q3 | $10.3M | Buy |
489,971
+67,815
| +16% | +$1.43M | ﹤0.01% | 3125 |
|
|
2020
Q2 | $12.2M | Buy |
422,156
+87,660
| +26% | +$2.53M | ﹤0.01% | 3015 |
|
|
2020
Q1 | $11.7M | Sell |
334,496
-42,061
| -11% | -$1.47M | ﹤0.01% | 2872 |
|
|
2019
Q4 | $9.2M | Buy |
+376,557
| New | +$9.2M | ﹤0.01% | 3244 |
|